| Motile sperm domain containing protein 2, integrin beta2 and cd63 |
2022-3-28 |
2022-10-06 |
|
| Treatment methods using adenovirus |
2022-3-22 |
2022-10-20 |
|
| Methods of anti-tumor therapy |
2021-10-10 |
2021-12-01 |
|
| Protein 2 antibodies containing motile sperm domains and methods of use thereof |
2021-9-09 |
2023-9-05 |
|
| Motile sperm domain containing protein 2 antibodies and methods of use thereof |
2021-9-09 |
2022-3-17 |
|
| Methods of anti-tumor therapy |
2021-9-06 |
2021-10-31 |
|
| Oxidized lipids and treatment or prevention of inflammation or infectious … |
2021-4-02 |
2021-10-07 |
|
| Motile sperm domain containing protein 2 and cancer |
2020-10-13 |
2021-4-01 |
|
| Motile sperm domain containing protein 2 and inflammation |
2020-9-14 |
2021-3-18 |
|
| Bispecific antibodies to mospd2 and t cell- or nk cell-specific molecules |
2020-9-10 |
2020-10-29 |
|
| Methods and compositions for tumor radiosensitization |
2020-8-27 |
2021-3-11 |
|
| Diagnostic methods for anti-angiogenic agent therapy |
2020-4-20 |
2020-6-30 |
|
| Methods of inducing responsiveness to anti-angiogenic agent |
2019-7-08 |
2020-2-13 |
|
| Oxidized lipids and treatment or prevention of fibrosis |
2018-7-16 |
2019-2-19 |
2019-2-19 |
| Formulations and Dosage Forms of Oxidized Phospholipids |
2018-6-08 |
2019-1-10 |
|
| Oxidized lipids and methods of use thereof |
2017-8-16 |
2019-11-05 |
2019-11-05 |
| Method for use of specific anti-angiogenic adenoviral agent |
2017-4-25 |
2017-10-12 |
|
| High-Purity Phospholipids |
2017-2-13 |
2017-8-31 |
|
| Method and composition to increase radiation-induced tumor therapeutic effects |
2016-7-12 |
2018-1-18 |
|
| Compositions and methods for treating glioblastoma GBM |
2016-1-07 |
2016-7-14 |
|
| Oxidized lipid compounds and uses thereof |
2015-7-16 |
2016-1-08 |
|
| Methods for treating psoriasis and vascular inflammation |
2015-3-23 |
2015-10-02 |
|
| Combined Treatment Utilizing VB-201 |
2015-2-13 |
2016-1-14 |
|
| Promoters exhibiting endothelial cell specificity and methods of using same for … |
2014-10-06 |
2015-3-26 |
|
| Endothelial Cell-Specific Polynucleotides and Use Thereof |
2014-9-24 |
2015-4-23 |
|
| Treatment of inflammation |
2014-6-12 |
2014-8-03 |
|
| Improved preparing method of oxidized phospholipid |
2014-1-06 |
2014-5-15 |
|
| Promoters exhibiting endothelial cell specificity and methods of using same for … |
2013-10-21 |
2014-6-05 |
|
| PROTECTORS INDICATORS OF ADMINISTRATIVE CELLS AND METHODS OF USING THESE |
2013-8-08 |
2016-8-31 |
|
| Improved method for producing oxidized phospholipid |
2013-7-09 |
2013-11-14 |
|
| Methods of Producing Adenovirus Vectors and Viral Preparations Generated … |
2013-3-14 |
2013-11-07 |
|
| Promoters exhibiting endothelial cell specificity and methods of using same |
2013-3-13 |
2014-10-14 |
2014-10-14 |
| Polynucleotide constructs, pharmaceutical compositions and methods for targeted … |
2013-3-05 |
2014-12-23 |
2014-12-23 |
| Oxidized lipids and uses thereof in treatment of inflammatory diseases and … |
2012-11-27 |
2013-5-02 |
|
| High-Purity Phospholipids |
2012-11-09 |
2013-3-28 |
|
| Combined treatment utilizing vb-201 |
2012-10-21 |
2012-12-31 |
|
| Formulations and dosage forms of oxidized phospholipids |
2012-8-31 |
2016-2-02 |
|
| Formulations and dosage forms of oxidized phospholipids |
2012-8-31 |
2015-12-30 |
|
| PHARMACEUTICAL COMPOSITION, PROCESS FOR THE PRODUCTION OF A PHARMACEUTICAL … |
2012-8-31 |
2021-12-21 |
|
| Polypeptides and Polynucleotides Encoding Same and Use Thereof in the Treatment … |
2012-7-12 |
2014-7-03 |
2014-7-03 |
| Specific anti-angiogenic adenoviral agent and uses thereof |
2012-7-05 |
2017-3-30 |
|
| Compositions for treating glioblastoma gbm and uses thereof |
2012-7-05 |
2017-9-28 |
|
| Promoters Exhibiting Endothelial Cell Specificity and Methods of Using Same for … |
2012-6-15 |
2012-7-12 |
|
| Method of synthesizing oxidized phospholipid and pharmaceutical composition for … |
2012-3-16 |
2012-8-09 |
|
| Improved Process for the Preparation of Oxidized Phospholipids |
2011-12-22 |
2012-1-19 |
|
| Improved Process for the Preparation of Oxidized Phospholipids |
2011-12-22 |
2013-8-08 |
2013-8-08 |
| Promoters exhibiting endothelial cell specificity and methods of using same |
2011-12-02 |
2012-7-20 |
|
| Isolated polynucleotides and nucleic acid constructs for directing expression … |
2011-10-12 |
2012-4-26 |
|
| Oxidized lipid compounds and uses thereof |
2011-5-05 |
2016-8-31 |
|
| Oxidized thiophospholipid compounds and uses thereof |
2011-4-05 |
2011-6-30 |
|
| Process for the preparation of oxidized phospholipids |
2011-3-17 |
2013-4-30 |
|
| Promoters exhibiting endothelial cell specificity and methods of using same for … |
2010-10-31 |
2014-6-30 |
|
| Platelet-activating factor (paf) analogs and uses thereof |
2010-4-15 |
2010-11-30 |
|
| Nucleic acid constructs for inhibition of angiogenesis |
2009-10-26 |
2014-6-30 |
|
| Oxidized thiophospholipid compounds and uses thereof |
2009-10-01 |
2010-6-03 |
|
| Endothelial cell specific promoter and methods of use |
2009-1-29 |
2015-9-24 |
|
| Platelet-activating factor (paf) analogs and uses thereof |
2008-10-05 |
2010-3-04 |
|
| Promoters exhibiting endothelial cell specificity and methods of using same for … |
2008-8-19 |
2009-5-04 |
|
| Compositions containing beta 2-glycoprotein i-derived peptides for the … |
2007-10-14 |
2008-1-20 |
|
| Promoters exhibiting endothelial cell specificity and methods of using same for … |
2007-5-14 |
2007-8-19 |
|
| Promoters exhibiting endothelial cell specificity and methods of using same for … |
2007-2-22 |
2008-11-12 |
|
| Promoters Exhibiting Endothelial Cell Specificity and Methods of Using Same for … |
2007-2-22 |
2010-11-11 |
|
| Methods employing and compositions containing defined oxidized phospholipids … |
2006-7-20 |
2006-12-10 |
|
| Compositions containing beta 2-glycoprotein i-derived peptides for the … |
2006-4-11 |
2009-1-08 |
|
| Compositions containing beta 2-glycoprotein i for the prevention and/or … |
2005-9-25 |
2009-7-29 |
|
| Composição farmacêutica, processo para a produção de uma composição … |
2012-8-31 |
2021-12-21 |
|